Posts Tagged: travel and entertainment expenses
Technology firm PTC Inc. said in a securities filing Monday it has reserved $28.2 million for a possible settlement with the DOJ and SEC of apparent FCPA offenses in China.
PTC said it has reached agreement in principle to settle the fed’s investigation into “expenditures [in China], including for travel and entertainment, that apparently benefited employees of customers regarded as state owned enterprises in China.”… Continue Reading
The Securities and Exchange Commission Wednesday charged global resources company BHP Billiton with violating the Foreign Corrupt Practices Act when it sponsored foreign government officials as guests at the 2008 Summer Olympics in Beijing.… Continue Reading
In a speech Tuesday at CBI’s Annual Pharmaceutical Compliance Congress in Washington D.C., the head of the SEC’s enforcement division, Andrew Ceresney, left, talked about the most common ways pharmas violate the FCPA.… Continue Reading
The Securities and Exchange Commission Monday charged Bruker Corporation with violating the Foreign Corrupt Practices Act by paying for sightseeing trips and shopping expenses for Chinese government officials responsible for buying the company’s products.… Continue Reading
Beauty products company Avon said Thursday it has “reached an understanding” with the DOJ and SEC for settlement of FCPA offenses.
The company said the resolution will include payment of $135 million for “alleged violations of the books and records and internal control provisions of the FCPA.”… Continue Reading
Qualcomm Inc, the world’s biggest mobile chipmaker, could face a FCPA enforcement action over alleged bribery to officials in China’s state-owned firms, the company disclosed in an SEC filing Wednesday.
Qualcomm said it received a Wells Notice on March 13 from the SEC’s Los Angeles Regional Office that recommends an enforcement action against the company for bribery in China.… Continue Reading
SciClone Pharmaceuticals Inc. said Friday that an investigation launched three years ago into possible FCPA violations in China is ongoing and the SEC has issued a new subpoena focused on ‘sales and marketing expenses’ by its NovaMed unit there.… Continue Reading
China state media reported Friday that police have detained 18 more people in the growing bribery investigation of U.K. drug maker GlaxoSmithKline.